We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy


CAR T Cells: A Living Targeted Drug, With Dr Matt Cooper

Video   Mar 10, 2021


In this installment of Teach Me in 10, we're joined by Matt Cooper, co-founder and chief scientific officer at Wugen, Inc. He is also assistant professor of medicine at Washington University. Matt discusses what T cells are and how they can be engineered to recognize cancer cells.

This can be achieved by incorporating a specific receptor – the chimeric antigen receptor (CAR) – which results in the generation of CAR T cells.

“CAR T cells are essentially a living targeted drug,” – Matt Cooper.
Learn more about the key challenges related to engineering CAR T cells, discover ways to enable the broader application of these cells and hear about the development of allogeneic CAR T cells as an “off-the-shelf” treatment for cancer.

For more information on CAR T cells, check out:

Treating Cancer – 5 Types of Immunotherapy

Opinionated Science Episode 14: Cancer Immunotherapy: Vaccines, Viruses and Nobel Prizes

Cancer and the Immune System

Visit the Teach Me in 10 hub page for more < 10 minutes science!

More Information

Recommended Videos

The Next Generation of Vaccines and Antiviral Drugs


Antiviral medicines and vaccines are both critical tools in our therapeutic arsenal for combating viral outbreaks. Discover more about vaccines and antivirals in this video from Scripps Research.


Introduction to ICP-MS – Part II


In part two of their ICP-MS Teach Me in 10, Abe Gutierrez and Ed McCurdy help to answer the question: Why do we need triple quadrupole ICP-MS?


Cubis® II Compliance


For customers requiring Pharmaceutical and GxP compliance, the Cubis®️ II platform is the only laboratory balance on the market today that offers fully customizable hardware, software and connectivity.



Like what you just watched? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free